gsk plc acronym former name glaxosmithkline plc british multinational pharmaceutical biotechnology company global headquarters established merger glaxo wellcome smithkline beechamn gsk tenth largest pharmaceutical company fortune global ranked behind pharmaceutical companies china resources sinopharm johnson johnson pfizer roche abbvie novartis bayer merck sharp company primary listing london stock exchange constituent ftse index august market capitalisation billion eighth largest london stock secondary listing new york stock exchange company developed first malaria vaccine rtss said would make available five per cent legacy products developed gsk include several listed world health organizations list essential medicines amoxicillin mercaptopurine pyrimethamine prosecution united states department justice doj based combined investigations department health human services hhsoig fda fbi primarily concerning sales marketing drugs avandia paxil wellbutrin gsk pleaded guilty promotion drugs unapproved uses failure report safety data kickbacks physicians united states agreed pay billion settlement largest healthcare fraud case date us largest settlement drug joseph nathan co founded general trading company wellington new zealand londoner joseph edward began producing driedmilk baby food excess milk produced dairy farms near bunnythorpe resulting product first known defiance glaxo lacto sold slogan glaxo builds bonnie glaxo laboratories sign still visible car repair shop main street bunnythorpe companys first pharmaceutical product released vitamin glaxo laboratories incorporated distinct subsidiary company london joseph nathans shareholders reorganised groups structure making glaxo obtained listing london stock glaxo acquired allen hanburys scottish pharmacologist david jack hired researcher allen hanburys years glaxo took went lead companys research development rd glaxo bought meyer laboratories began play important role us market american arm glaxo inc moved research triangle park us headquartersresearch zebulon us manufacturing north burroughs wellcome company founded london american pharmacists henry wellcome silas wellcome tropical research laboratories opened burroughs wellcome established research manufacturing facilities tuckahoe new served us headquarters company moved research triangle park north carolina nobel prize winning scientists gertrude b elion george h hitchings worked invented drugs still used many years later wellcome foundation bought cooper mcdougall robertson inc become active animal burroughs wellcome decided move headquarters company selected paul rudolph design new elionhitchings building celebrated worldwide built according paul rudolph heritage foundation president kelvin dickinson alex sayf cummings georgia state university wrote iconic building helped define image rtp saying love hate rudolphs design remains impressively audacious creative gesture important part history architecture research triangle united therapeutics bought building announced plans tear glaxo wellcome merged form glaxo wellcome merger considered biggest uk corporate glaxo wellcome restructured rd operation year cutting jobs worldwide closing rd facility beckenham kent opening medicines research centre stevenage also year glaxo wellcome acquired californiabased affymax leader field combinatorial glaxo wellcome become worlds thirdlargest pharmaceutical company revenues behind novartis merck global market share around per products included imigran treatment migraine salbutamol ventolin treatment asthma zovirax treatment coldsores retrovir epivir treatment aids company worlds largest manufacturer drugs treatment asthma employed people including uk operating companies manufacturing facilities worldwide seven products among worlds top bestselling pharmaceuticals company rd facilities hertfordshire kent london verona italy manufacturing plants scotland north england rd centres us japan production facilities us europe far thomas beecham launched beechams pills laxative england giving birth beecham group beecham opened first factory st helens lancashire beecham extensively involved pharmaceuticals consumer products macleans toothpaste lucozade synthetic penicillin john k smith opened first pharmacy philadelphia mahlon kline joined business years later became smith kline co merged french richard company changed name smith kline french laboratories focused research years later bought norden laboratories business research animal health recherche et industrie thérapeutiques belgium focus vaccines company began expand globally buying seven laboratories canada united states bought allergan manufacturer eye skincare smith kline french merged beckman inc changed name smithkline bought international clinical smithkline beckman merged beecham group form smithkline beecham headquarters moved united states england expand rd united states company bought new research center another opened england new frontiers science park glaxo wellcome smithkline beecham announced intention merge january merger completed december year forming glaxosmithkline companys global headquarters gsk house brentford london officially opened thenprime minister tony blair building erected cost million home administrative gsk completed acquisition new jerseybased block drug gsk acquired usbased consumer healthcare company cns inc whose products included breathe right nasal strips fiberchoice dietary supplements million chris gent previously ceo vodafone appointed chairman board gsk opened first rd centre china shanghai initially focused neurodegenerative andrew witty became chief executive officer witty joined glaxo president gsks pharmaceuticals europe since gsk acquired stiefel laboratories worlds largest independent dermatology drug company november fda approved gsks vaccine influenza protection manufactured companys id biomedical corp also november gsk formed joint venture pfizer create viiv healthcare specializes hiv company acquired laboratorios phoenix argentine pharmaceutical company ukbased sports nutrition company maxinutrition million deal prestige brands holdings took gsk brands sales million including bc powder beano ecotrin fiber choice goodys powder sominex company announced would invest million manufacturing facilities ulverston northern england designating site previously announced biotech may year acquired cellzome german biotech company june worldwide rights alitretinoin toctino eczema drug gsk acquired human genome sciences hgs billion companies collaborated developing lupus drug belimumab benlysta albiglutide type diabetes darapladib september sold beverage division suntory included brands lucozade ribena however deal include march gsk paid billion raise stake indian pharmaceutical unit glaxosmithkline pharmaceuticals per cent part move focus emerging april novartis glaxo agreed billion deals novartis selling vaccine business gsk buying gsks cancer february gsk announced would acquire glycovaxyn swiss pharmaceutical company june year would sell two meningitis drugs pfizer nimenrix mencevax around philip hampton time chair royal bank scotland became gsk chairman september march emma walmsley became ceo first female ceo december reuters reported glaxo increased stake saudi arabian unit taking control saudi partner banaja ksa holding respect rare diseases company divested portfolio gene therapy drugs orchard therapeutics april november reuters reported unilever prime position acquire gsks interest indian unit glaxosmithkline consumer healthcare ltd sale could generate around billion nestlé cocacola also reported interested business unit look strengthen presence december gsk announced unilever would acquire indianlisted glaxosmithkline consumer healthcare business billion billion unilever pay majority deal cash remaining paid shares indian operation hindustan unilever limited upon completion gsk around hindustan unilever limited selling shares number day company also announced would acquire oncology specialist tesaro billion deal give gsk control ovarian cancer treatment zejula member class poly adp ribose polymerase parp october gsk agreed sell rabies vaccine rabavert tickborne encephalitis vaccine encepur bavarian nordic billion july gsk acquired stake german biotech company march gsk announced reached agreement novartis acquire novartiss stake consumer healthcare joint venture billion december gsk announced along pfizer reached agreement merge combine consumer healthcare divisions single entity combined entity would sales around billion billion gsk maintaining controlling stake joint venture pfizer would remaining shareholding deal builds earlier deal gsk bought novartis stake gsknovartis consumer healthcare joint culmination consumer healthcare string deals result gsk splitting two separate companies via demerger subsequent listing joint venture create two publicly traded companies one focusing pharmaceuticals research development consumer healthcare february gsk announced spinoff consumer healthcare company called january company announced received three unsolicited offers unilever acquire consumer healthcare business unit final proposal valuing business unit billion billion cash plus billion unilever subsequently gsk declined outside offersattempts acquire consumer healthcare business moved forward plan complete demerger main biopharmaceutical april business announced would acquire sierra oncology inc billion per may gsk announced would acquire affinivax phase ii pneumococcal vaccine candidate billion strengthening vaccine may company changed name glaxosmithkline april gsk announced would acquire bellus health inc gsk manufactures products major disease areas asthma cancer infections diabetes mental health medicines historically discovered developed gsk legacy companies sold generics include bacterial infections zidovudine hiv infection valacyclovir herpes virus infections albendazole parasitic infections sumatriptan migraine lamotrigine epilepsy bupropion paroxetine major depressive disorder cimetidine ranitidine gastroesophageal reflux disorder treatment leukemia allopurinol pyrimethamine antibacterial among albendazole amoxicillin amoxicillinclavulanate allopurinol mercaptopurine mupirocin pyrimethamine ranitidine thioguanine trimethoprim zidovudine world health organizations list essential gsk applied regulatory approval first malaria malaria responsible deaths annually mainly known rtss vaccine developed joint project path vaccines initiative bill melinda gates foundation company committed making vaccine available developing countries five per cent cost rtss uses gsks proprietary adjuvant examined phase trial eight african countries path reported period following vaccination rtss conferred approximately protection clinical plasmodium falciparum disease children aged months approximately protection children aged weeks administered conjunction expanded program immunization epi glaxo said spent million expected spend additional million seeking regulatory gsks consumer healthcare division earned billion sells oral healthcare including aquafresh macleans sensodyne toothpastes gsk also previously owned lucozade ribena brands soft drinks sold suntory products include abreva treat cold sores night nurse cold remedy breathe right nasal strips nicoderm nicorette nicotine march recalled alli overthecounter weightloss drug united states puerto rico possible tampering following customer gsk offices countries employed people rd companys single largest market united states us headquarters philadelphia pennsylvania durham north carolina consumerproducts division moon township july uk government signed million doses vaccine developed gsk sanofi uses recombinant proteinbased technology sanofi gsks pandemic technology companies claimed able produce one billion doses subject successful trials regulatory approval first half company also agreed billion deal united states produce million doses sr one established smithkline beecham invest new biotechnology companies continued operating gsk formed gsk formed another subsidiary gsk ventures outlicense start new companies around drug candidates intend develop sr one tended invest company aligned gsks september avalon ventures announced entered definitive agreement glaxosmithkline gsk acquisition sitari pharmaceuticals gsk includes transglutaminase small molecule program treatment celiac four glaxosmithkline scientists recognized nobel committee contributions basic medical science andor therapeutics development since glaxosmithkline several times ranked first among pharmaceutical companies global access medicines index funded bill melinda gates human rights campaign lgbtrights advocacy group gave gsk score per cent corporate equality gsk active world health organization global alliance eliminate lymphatic filariasis gaelf around million people globally believed infected lymphatic company endorsed london declaration neglected tropical diseases agreed donate million albendazole tablets year fight soiltransmitted helminthiasis provide million albendazole tablets every year lymphatic filariasis disease billion treatments delivered countries disease considered endemic progressed surveillance company said would cut drug prices per cent poorest nations release intellectual property rights substances processes relevant neglected disease patent pool encourage new drug development invest per cent profits leastdeveloped countries medical infrastructure médecins sans frontières welcomed decision criticized gsk failing include hiv patents patent pool including middleincome countries gsk licensed hiv portfolio medicines patent pool use children agreed negotiate license dolutegravir integrase inhibitor clinical license extended include dolutegravir adults hiv licenses include countries per cent adults per cent children hiv also gsk joined alltrials british campaign ensure clinical trials registered results reported company said would make past clinicaltrial reports available future ones within year studies gsk largely access strategy providing medicines subsidized price lower middle income markets including africa former ceo andrew witty new ceo emma shifted away gsk exiting subsaharan african markets plans provide newer expensive oncology genetics pipeline glaxo group ltd glaxo imperial chemical industries ici owned patents covering various aspects antifungal drug nn created patent pool crosslicensing patents subject express licensing restrictions chemical finished form drug tablets capsules made must resold bulk form licensed drug companies sell drug finished form subject similar effect intent bulksale restriction keep drug chemical hands small companies might act pricecutters effect maintain stable uniform united states brought antitrust suit two states v glaxo group violation sherman act also seeking patents declared trial court found defendants engaged several unlawful conspiracies dismissed part suit seeking invalidation patents refused grant relief mandatory sales bulk drug chemical compulsory licensing government appealed supreme court reversed united states v glaxo group ltd us concerns sugar vitamin content ribena blackcurrantbased syrup soft drink owned gsk produced england hw carter co companys unbranded syrup distributed children source vitamin c world war ii gave drink reputation good health beecham bought h w carter british advertising standards authority asa required gsk withdraw claim ribena toothkind lowersugar variety encourage tooth decay company poster showed bottles toothkind place bristles toothbrush asas ruling upheld high gsk fined new zealand claim readytodrink ribena contained high levels vitamin c found contain detectable vitamin gsk sold ribena another drink lucozade japanese multinational suntory us department justice announced gsk would pay million criminal fine forfeiture civil settlement million false claims act fines stemmed production improperly made adulterated drugs gsks subsidiary sb pharmco puerto rico inc cidra puerto rico time produced billion products year drugs involved kytril antiemetic bactroban used treat skin infections paxil antidepressant avandamet diabetes gsk closed factory case began gsk sent experts fix problems cited fda lead inspector recommended recalls defective products authorised fired filed whistleblower lawsuit federal marshals seized billion worth products largest seizure history settlement sb pharmco pleaded guilty criminal charges agreed pay million criminal fine forfeiture time largest payment ever manufacturer adulterated drugs million civil penalties settle civil pandemrix influenza vaccine developed glaxosmithklinefin used finland sweden mass vaccination population swine flu pandemic august swedish medical products agency mpa finnish national institute health welfare thl launched investigations regarding development narcolepsy possible side effect pandemrix flu vaccination found increased risk among children youths resulting additional cases narcolepsy per vaccinated february finnish national institute health welfare thl concluded clear connection pandemrix vaccination campaign narcolepsy epidemic finland total cases narcolepsy found finland ninety per cent received pandemrix sweden however observed influenza cases totally especially compared reported british department health paying sodium oxybate medication patients taking legal action problems linked use swine flu vaccine cost government per patient per july gsk pleaded guilty united states criminal charges agreed pay billion largest settlement justice department drug company billion included criminal fine forfeiture remaining billion covered civil settlement government false claims act investigation launched largely basis information four whistleblowers filed qui tam whistleblower lawsuits company false claims charges stemmed gsks promotion antidepressants paxil paroxetine wellbutrin bupropion unapproved uses specifically suitable patients age failure report safety data avandia rosiglitazone violation federal food drug cosmetic act drugs promoted unapproved uses two inhalers advair fluticasonesalmeterol flovent fluticasone propionate well zofran ondansetron imitrex sumatriptan lotronex alosetron valtrex settlement also covered reporting false best prices underpaying rebates owed medicaid drug rebate program kickbacks physicians prescribe gsks drugs allexpensespaid spa treatments hunting trips doctors spouses speakers fees conferences payment articles ghostwritten company placed physicians medical company set ghostwriting programme called caspper initially produce articles paxil extended cover part settlement gsk signed fiveyear corporate integrity agreement department health human services obliged company make major changes way business including changing compensation programmes sales force executives implement maintain transparency research practices publication announced would longer pay doctors promote drugs attend medical conferences sales staff would longer prescription settlement included criminal fine failing report safety data fda avandia rosiglitazone diabetes drug approved civil settlement million making false claims justice department said gsk promoted rosiglitazone physicians misleading information including conferred cardiovascular benefits despite fdamandated label warning cardiovascular john buse diabetes specialist told medical conferences rosiglitazone might carry increased risk cardiovascular problems gsk threatened sue called university head department persuaded sign gsk raised questions internally drugs safety company ghostwrote article circulation describing gsk funded clinical trial suggested rosiglitazone might beneficial effect cardiovascular reports began link thiazolidinediones class drugs rosiglitazone belongs heart april year gsk began sixyear openlabel randomized trial known record examine rosiglitazone cardiovascular two gsk metaanalyses showed increased risk cardiovascular problems rosiglitazone information passed fda posted company website otherwise published december rosiglitazone become topselling diabetes drug annual sales june new england journal medicine published metaanalysis associated drug increased risk heart gsk reportedly tried persuade one authors steven nissen publish receiving advance copy one journals peer reviewers gsk july fda scientists suggested rosiglitazone caused excess heart attacks fda placed restrictions drug including adding boxed warning withdraw fda rejected drug caused excess heart senate finance committee inquiry concluded gsk sought intimidate scientists concerns february year company tried halt publication editorial controversy nissen european heart results gsks record trial published june confirmed association rosiglitazone increased risk heart failure fractures heart attack concluded increase risk overall cardiovascular morbidity mortality compared standard glucoselowering steven nissan kathy wolkski argued studys low event rates reduced statistical september rosiglitazone suspended results record study confirmed duke clinical research institute independent review required november year fda lifted restrictions placed boxed warning heart attack removed warning heart failure remained gsk fined promoting paxilseroxat paroxetine treating depression although drug approved pediatric paxil billion worldwide sales company conducted nine clinical trials none showed paxil helped children promoted drug paying physicians go allexpenses paid trips fivestar hotels paxils label along similar drugs included fdamandated boxed warning might increase risk suicidal ideation behaviour patients internal smithkline beecham document said withheld data two gsk studies would commercially unacceptable include statement pediatric efficacy demonstrated would undermine profile company ghostwrote article published journal american academy child adolescent psychiatry misreported results one clinical trials study article concluded paxil generally well tolerated effective major depression suppression research findings subject book side effects alison years gsk marketed paxil nonhabit forming patients filed classaction suit alleging withdrawal symptoms los angeles court issued injunction preventing gsk advertising drug habit court withdrew injunction fda objected court jurisdiction drug marketing fda world health organization committee reported paxil among top drugs top three antidepressants dependence company also fined promoting wellbutrin bupropion approved time major depressive disorder also sold smokingcessation aid zyban weight loss treatment attention deficit hyperactivity disorder sexual dysfunction substance addiction gsk paid doctors promote offlabel uses set supposedly independent advisory boards continuing medical education chinese authorities announced since gsk funnelled billion kickbacks gsk managers doctors hospitals others prescribed drugs using travel agencies consulting chinese authorities arrested four gsk executives part fourmonth investigation claims doctors bribed cash sexual chinese court found company guilty bribery imposed fine million mark reilly british head gsks chinese operations received threeyear suspended prison sentence oneday trial held reilly reportedly deported china dismissed february company fined million uk competition markets authority paying generics uk alpharma norton healthcare keep generic varieties paroxetine uk market generics companies fined million end generics became available uk price paroxetine dropped per italian police sought bribery charges may doctors gsk employees gsk predecessor accused spent physicians pharmacists others giving cameras computers holidays cash doctors alleged received cash based number patients treated cancer drug topotecan following month prosecutors munich accused doctors accepted bribes smithkline beecham inquiry opened allegations company given hospital doctors money free charges dismissed verona court january united states gsk settled largest tax dispute irs history agreeing pay billion issue zantac products sold case revolved around intracompany transfer share profit attributable us subsidiaries gsk subject tax uks serious fraud office sfo opened criminal inquiry gsks sales practices using powers granted bribery act sfo said collaborating chinese authorities investigate bringing charges uk related gsks activities china europe middle also us department justice investigating gsk reference foreign corrupt practices october gsk told staff work disable contact tracing function nhs testandtrace app monitors spread gsk explained reason due social distancing measures place sites rendering technology lorenzetti laura july glaxosmithkline seeks approval firstever malaria vaccine fortune simon neville glaxosmithkline fined bribing doctors increase drugs sales guardian july researchbased pharma pledges neglected tropical diseases pharma letter january frank vernon thank ribena archived april wayback machine bristol post september michael regester judy larkin risk issues crisis management public relations kogan page publishers p haffner sm greenberg weston wm et al august effect rosiglitazone treatment nontraditional markers cardiovascular disease patients type diabetes mellitus circulation pmid record rosiglitazone evaluated cardiac outcomes regulation glycaemia diabetes full text view clinicaltrialsgov march retrieved march andrew clark glaxos handling avandia concerns damned us senate committee guardian february komajda mcmurray jj becknielsen h gomis r hanefeld pocock sj curtis ps jones np home pd heart failure events rosiglitazone type diabetes data record clinical trial eur heart j pmc pmid fda responds steve nissens criticism upcoming avandia meeting forbes may company hid suicide link bbc news january secrets drug trials bbc panorama january goldacre pp ronald white los angeles times august us opposes order pull paxil tv ads philips tom july chinese police allege glaxo sales reps trained offer sexual bribes daily telegraph archived original january httpsenwikipediaorgwikigskplc